450950.KQ ASTERASYS Co.,Ltd

Healthcare Medical Devices KOSDAQ
4,915 KRW
Close of Oct 31, 2026
4,050 17,165
Market cap
KRW 185B
P/E
30.7x
P/B
4.09x
ROE
1.5%
Dividend yield
1.66%
Fundamental score
1.6/5

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is 450950.KQ undervalued?

Graham number
Price4,915
Graham value2,081
Premium136.2%

450950.KQ trades 136.2% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

ASTERASYS Co.,Ltd fundamental analysis

8 of 22 checks passed

ROE 0/2

Low return on equity (1.5%), below 10%.

ROA 1/1

Return on assets (1.3%) is above the industry median (-9.3%).

Profit Consistency 1/2

Profitable for 4 consecutive years.

Earnings Growth 5Y 0/1

Earnings per share history is shorter than 5 years.

Earnings Acceleration 0/1

Not enough positive earnings history to compare last year's growth with the 5-year average.

Earnings Growth vs Industry 1/1

Last year's EPS growth (67.5%) is above the industry median (-3.8%).

Revenue Growth 2/2

Revenue grew 34.4% a year over the past 3 years.

Short-term Liquidity 1/1

Current assets cover short-term liabilities.

Long-term Liabilities 1/1

Current assets cover long-term liabilities.

Debt to Equity 0/2

Debt to equity cannot be calculated: debt is not reported or equity is negative.

Debt Trend 0/1

Debt to equity has risen over the past 5 years.

Debt Coverage 0/1

Debt is not reported.

Interest Coverage 0/1

EBIT is negative, against interest expense, below 5x.

PE vs Market 0/1

PE (30.7x) is above the market median (11.3x).

PE vs Industry 0/1

PE (30.7x) is above the industry median (22.5x).

PBV 0/1

Price to book (4.1x) is above the industry median (3.5x).

Graham Number 0/1

The price is above the Graham number (PE x PB = 125.6, limit 22.5).

PEG 0/1

PEG needs positive PE and positive 5-year earnings growth.

Dividend Yield 1/2

Dividend yield (1.7%) is above the bottom 25% of dividend payers in the market.

Dividend Stability 0/2

Dividends were not paid steadily for the past 5 years.

Dividend Growth 0/1

Dividends paid did not grow over the past 5 years.

Payout Ratio 1/1

Payout ratio is 33.3%, covered by earnings.

Each check is worth 1 or 2 points by how much it says about the quality of the company. The score is the share of points earned, out of 5. Ask AI to explain this score

ASTERASYS Co.,Ltd stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About ASTERASYS Co.,Ltd

ASTERASYS Co.,Ltd manufactures and sells medical equipment for hospitals and skin care devices for beauty care clinics and salons in South Korea, Europe, Asia, the Middle East, Africa, North America, South America, Australia, and New Zealand. The company offers Coolfase, a monopolar RF device with direct cooling in tip; Q-facial, a skin management equipment; Liftera for facial skin lifting; Liftera2, a dual-type HIFU technology that enables combination treatments using Line …

Full company profile